Effects of epigallocatechin gallate on the proliferation and apoptosis of the nasopharyngeal carcinoma cell line CNE2

Experimental and Therapeutic Medicine

Volumn 8, Issue 6, 2014, Pages 1783-1788

  Zhang, Weijun ^a,b   Yang, Ping ^c   Gao, Fei ^a   Yang, Jie ^a   Yao, Kaitai ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c Dongguan Donghua Hospital   (China)

Author keywords

Epigallocatechin gallate; Nasopharyngeal carcinoma CNE2 cells; Telomerase; Telomerase reverse transcriptase

Indexed keywords

EPIGALLOCATECHIN GALLATE; MICRORNA; MYC PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE;

APOPTOSIS; ARTICLE; CELL COUNTING; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MRNA EXPRESSION ASSAY; NASOPHARYNX CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84908161703     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.2020     Document Type: Article

References (22)

1. Gao: Nasopharyngeal carcinomas. XianZhi Gu (ed). Peking Union Medical College press, Beijing, p433, 2008.
2. Kim JH, Liu L, Lee SO, et al: Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis. Cancer Res 65: 6312, 2005.
3. Tachibana H: Molecular basis for cancer chemoprevention by green tea polyphenol EGCG. Forum Nutr 61: 156-169, 2009.
4. Zhang Y, Han G, Fan B, et al: Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity. Eur J Pharmacol 606: 172-179, 2009.
5. Hayakawa S, Sacki K, Sazuka M, et al: Apoptosis induction by epigallocatechin gallate involves its binding to Fas. Biochem Biophys Res Commun 285: 1102-1106, 2001.
6. Chen D, Daniel KG, Kuhn DJ, et al: Green tea and tea polyphenols in cancer prevention. Front Biosci 9: 2618-2631, 2004.
7. Shankar S, Ganapathy S and Srivastava RK: Green tea polyphenols: biology and therapeutic implications in cancer. Front Biosci 12: 4881-4899, 2007.
8. Khan N and Mukhtar H: Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 269: 269-280, 2008.
9. Zhao Y, Yang LF, Ye M, Gu HH and Cao Y: Induction of apoptosis by epigallocatechin-3-gallate via mitochondrial signal transduction pathway. Prev Med 39: 1172-1179, 2004.
10. Ma J, Wen ZS, Lin P, Wang X and Xie FY: The results and prognosis of different treatment modalities for solitary metastatic lung tumor from nasopharyngeal carcinoma: a retrospective study of 105 cases. Chin J Cancer 29: 787-795, 2010.
11. Mai HQ, Zeng ZY, Zhang CQ, et al: Elevated plasma big ET-1 is associated with distant failure in patients with advanced-stage nasopharyngeal carcinoma. Cancer 106: 1548-1553, 2006.
12. Han L, Lin SJ, Pan JJ, et al: Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Chin J Cancer 29: 145-150, 2010.
13. Ruan L, Wang GL, Yi H, et al: Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy. J Cell Biochem 110: 975-984, 2010.
14. Fountzilas G, Tolis C, Kalogera-Fountzila A, et al: Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study. Strahlenther Onkol 181: 223-230, 2005.
15. Chua DT, Ma J, Sham JS, et al: Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. J Clin Oncol 23: 1118-1124, 2005.
16. Rodriguez-Galindo C, Wofford M, Castleberry RP, et al: Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. Cancer 103: 850-857, 2005.
17. Gao WB and Weng GB: Anti-oxidant effects of green tea polyphenols and their mechanism: research advances. J Int Pharmaceutical Res 36: 332-335, 2009.
18. Chen L and Zhang HY: Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate. Molecules 12: 946-957, 2007.
19. Shankar S, Ganapathy S and Srivastava RK: Green tea polyphenols: biology and therapeutic implications in cancer. Front Biosci 12: 4881-4899, 2007.
20. Shammas MA, Koley H, Batchu RB, et al: Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential. Mol Cancer 4: 24, 2005.
21. Masutomi K, Yu EY, Khurts S, et al: Telomerase maintains telomere structure in normal human cells. Cell 114: 241-253, 2003.
22. Harrington L: Biochemical aspects of telomerase function. Cancer Lett 194: 139-154, 2003.